Augmenting the Genetic Alphabet

For the first time, synthetic DNA base pairs are replicated within living bacteria.

Written byKate Yandell
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SYNTHORXLiving organisms have two sets of DNA base pairs—adenine paired with thymine and cytosine paired with guanine—that together encode the 20 amino acids used to make proteins in the cell. Now, scientists at The Scripps Research Institute (TSRI) in La Jolla, California, have introduced a synthetic base pair to Escherichia coli, greatly expanding the information DNA is able encode. DNA containing the novel base pair can replicate within the bacteria, according to a paper published today (May 7) in Nature. The work advances the goal of creating cells with synthetic DNA elements that can produce proteins made with an expanded set of amino acids.

“This is the first paper to show the possibility that living organisms can have really artificial DNA with [an] expanded genetic alphabet,” Ichiro Hirao, a synthetic biologist at the RIKEN Center for Life Science Technologies in Japan, wrote in an e-mail to The Scientist. Hirao was not involved in the study, but is also working to incorporate synthetic base pairs into living organisms.

“What we’ve done is successfully finally gotten a cell that stably harbors increased genetic information,” said study coauthor Floyd Romesberg, a synthetic biologist at TSRI. “What we want to do next, and what my lab is already working on, is . . . to retrieve that information.”

With the help of more than a dozen graduate students and postdocs, Romesberg spent the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies